Takeda's experience in gastroenterology and immunology led to the recognition of an unmet need in an underserved community of patients suffering from a debilitating and life-changing disease. Takeda strives to amplify the voice of patients with EoE through disease education for HCPs, with the ultimate goal of advancing how doctors and patients manage EoE.
***Secondary causes of esophageal eosinophilia: gastroesophageal reflux disease, eosinophilic gastrointestinal disease, achalasia, hypereosinophilic syndrome, esophageal Crohn’s disease, infections (fungal, viral), connective tissue disorders, autoimmune disorders, vasculitis, drug hypersensitivity reactions, pill esophagitis, stasis esophagitis, graft versus host disease, Marfan syndrome type II, hyper-IgE syndrome, PTEN hamartoma tumor syndrome, Netherton’s syndrome, severe atopy metabolic wasting syndrome.
†††Recommendation in favor of empiric elimination diets is based on the published experience with the six food elimination diet (SFED). Patients who put a higher value on avoiding the challenges of adherence to diet involving elimination of multiple common food staples and the prolonged process of dietary reintroduction may reasonably decline this treatment option. Emerging data on less restrictive diets (4 food, milk elimination, 2-4-6 step up diet) may increase both provider and patient preference for diet therapy.
‡‡‡Patients who put a higher value on avoiding the challenges of adherence to an elemental diet and the prolonged process of dietary reintroduction may reasonably decline this treatment option.
§§§Due to the potential limited accuracy of the currently available, allergy based testing for the identification of specific food triggers for EoE, patients may prefer alternative medical or dietary therapies to an exclusively testing-based elimination diet.
||||||Esophageal dilation does not address the esophageal inflammation associated with eosinophilic esophagitis.
EoE symptoms, such as dysphagia and food impaction, may produce a certain amount of fear.9 Because some patients unknowingly develop adaptive behaviors to cope with EoE, they may be unaware of their symptoms.1,3,11,28,30,31 Diagnostic delays may increase the risk of fibrostenotic complications, and the mean diagnostic delay is up to 3.5 years in children and 8 years in adults.10,12,25
Use these questions to help uncover key symptoms in adult and pediatric patients.
Does your adult patient:
Does your pediatric patient*:
Does your pediatric patient*:
*For pediatric patients, the questions that uncover adaptive behaviors should change to reflect the patient's eating behaviors as those also change over time.30
Please note this is not a diagnostic tool. Symptoms vary by patient and not all patients with these symptoms have EoE.
If so, your patient may be suffering from symptoms of EoE. Consider
an endoscopy with biopsies to help assess esophageal inflammation
and confirm suspicions of EoE.1,3
GRADE=Grading of Recommendations Assessment, Development, and Evaluation.